MRSA Healthcare Facility In-patient Survey

This survey is designed to exemplify the potential of Keypoint in carrying out a large scale survey. Depending on the medium chosen, this can be carried out online in one data entry session or it can be saved and completed in more than one session. Collecting data for multiple facilities can be carried out at different times.

Part 1 - Facility-wide data

The questions in the first section relate to facility-wide information. If you are reporting for multiple facilities, then each facility should be entered separately. You can however adapt this so that if this survey was being used as a single survey across a multi-facility that the responses could be identified to a unit, ward or facility.

Q1.

Response Number

Q2.

How many infection prevention and control professionals are present at your facility?

Healthcare demographics

Q3.

Location of your healthcare facility

Q4.

Is your healthcare facility classed as

Q5.

Type of healthcare facility (check all that apply):

Q6.

Number of beds

Q7.

Number of inpatient's on day of survey:

Q8.

Which of the following are present in the healthcare facility (tick all that apply):

Q9.

What is the percentage of ICU beds of the total beds available?

Q10.

What type of Health care Associated Infections (HAI) routine surveillance do you perform?

Q11.

If targeted, please specify:

Q12.

Which site(s) of infection do you routinely survey:

Q13.

Do you perform active surveillance cultures for MRSA

Q14.

If yes, which of the following populations do you perform surveillance cultures? (Tick all that apply).

Q15.

Are your surveillance cultures:

Q16.

Which methods do you use for your surveillance cultures?

Q17.

Approximately on what percent of your total occupied beds do you perform active surveillance cultures for MRSA?

Q18.

On the day of your point prevalence survey, how many health care facility inpatients had cultures positive for MRSA?

Q19.

What type of isolation do you currently require for known MRSA culture positive patients?

Standard precautions only

Contact isolation

No isolation

Other

MRSA - Infected Patients - ICU

MRSA Infected Patients - Non ICU

MRSA colonized patients - ICU

MRSA colonised patients - Non ICU

Other

Part 2 - Individual care data

Provide the following information for each MRSA-positive patient from your point prevalence survey.

Q20.

Gender

Q21.

Age

Q22.

Service

Q23.

Duration: Admit to +MRSA

Q24.

Culture type

Q25.

Infections sites

Q26.

Underlying conditions

Q27.

Antibiotics

Resistant

Susceptible

Not tested

Trimethoprim-sulfamethoxazole

Clindamycin

Erythromycin

Gentamicin

Tetracycline

Levofloxicin

Other

Created by KeyPoint survey software